Mr. Cooper has served as a director of Quoin Inc. since May 2021. With 30 years of pharmaceutical industry experience, Mr. Cooper has held roles in operational, corporate development and general management. He recently served as the Chief of Strategy and Corporate Development for Resonea, Inc., a digital health company. Formerly, he was President at Boulder Cove and Executive VP of Corporate and Product Development at Medicis Pharmaceutical. He also served as the Chief Business Officer of NuvOx Pharmaceuticals, a clinical stage pharmaceutical company and as Chief Financial and Operating Officer for First Place, AZ, a non-profit healthcare services organization. Mr. Cooper’s leadership experience is in clinical research, product development, supply chain, business development and executive management in a broad range of therapeutic areas including dermatology, aesthetics, allergy, sleep apnea, stroke and orphan drugs. Mr. Cooper currently serves as a director of Sonoran Biosciences, a specialty pharmaceutical company. He has also served as a director of Bioenvision (Nasdaq: BIVN). Mr. Cooper holds an MBA from the WP Carey School of Business at Arizona State University and a BA from Northeastern Illinois University.